Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies

Infection and Immunity

Volumn 77, Issue 10, 2009, Pages 4548-4558

  Schwingel, Johanna M ^a,b   Edwards, Katie J ^a,b   Cox, Andrew D ^d   Masoud, Hussein ^d,e   Richards, James C ^d   St Michael, Frank ^d   Tekwe, Carmen D ^b   Sethi, Sanjay ^a,c   Murphy, Timothy F ^a,c   Campagnari, Anthony A ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF JORDAN   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; LIPOOLIGOSACCHARIDE; OLIGOSACCHARIDE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CARBOHYDRATE ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MORAXELLA CATARRHALIS; MORAXELLACEAE INFECTION; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE;

ADULT; ANTIBODIES, BACTERIAL; CARBOHYDRATE SEQUENCE; CHILD; CROSS REACTIONS; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MORAXELLA (BRANHAMELLA) CATARRHALIS; MUTATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEQUENCE ANALYSIS, DNA; SERUM;

EID: 70349429754     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00294-09     Document Type: Article

References (54)

1. Adlowitz, D. G., C. Kirkham, S. Sethi, and T. F. Murphy. 2006. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease. FEMS Immunol. Med. Microbiol. 46:139-146.
2. Ala'Aldeen, D. A., P. Stevenson, E. Griffiths, A. R. Gorringe, L. I. Irons, A. Robinson, S. Hyde, and S. P. Borriello. 1994. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 62:2984-2990.
3. Bakri, F., A. L. Brauer, S. Sethi, and T. F. Murphy. 2002. Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. J. Infect. Dis. 185:632-640.
4. Bogaert, D., P. van der Valk, R. Ramdin, M. Sluijter, E. Monninkhof, R. Hendrix, R. de Groot, and P. W. Hermans. 2004. Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. Infect. Immun. 72:818-823.
5. Buttenschoen, K., M. Kornmann, D. Berger, G. Leder, H. G. Beger, and C. Vasilescu. 2008. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbeck's Arch. Surg. 393:473-478.
6. Celli, B. R., W. MacNee, and ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23:932-946.
7. Ciucanu, I., and F. Kerek. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 131:209-217.
8. Edebrink, P., P. E. Jansson, M. M. Rahman, G. Widmalm, T. Holme, and M. Rahman. 1995. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr. Res. 266:237-261.
9. Edebrink, P., P. E. Jansson, M. M. Rahman, G. Widmalm, T. Holme, M. Rahman, and A. Weintraub. 1994. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:269-284.
10. Edebrink, P., P. E. Jansson, G. Widmalm, T. Holme, and M. Rahman. 1996. The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292. Carbohydr. Res. 295: 127-146.
11. Edwards, K. J., S. Allen, B. W. Gibson, and A. A. Campagnari. 2005. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J. Bacteriol. 187:2939-2947.
12. Edwards, K. J., J. M. Schwingel, A. K. Datta, and A. A. Campagnari. 2005. Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates. J. Clin. Microbiol. 43: 6139-6143.
13. Enright, M. C., and H. McKenzie. 1997. Moraxella (Branhamella) catarrhalis- clinical and molecular aspects of a rediscovered pathogen. J. Med. Microbiol. 46:360-371.
14. Furano, K., and A. A. Campagnari. 2003. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect. Immun. 71:1843-1848.
15. Holme, T., M. Rahman, P. E. Jansson, and G. Widmalm. 1999. The lipopolysaccharide of Moraxella catarrhalis: structural relationships and antigenic properties. Eur. J. Biochem. 265:524-529.
16. Hu, W. G., J. Chen, J. F. Battey, and X. X. Gu. 2000. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect. Immun. 68:4980-4985.
17. Hu, W. G., J. Chen, J. C. McMichael, and X. X. Gu. 2001. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect. Immun. 69:1358-1363.
18. Inzana, T. J., and M. A. Apicella. 1999. Use of a bilayer stacking gel to improve resolution of lipopolysaccharides and lipooligosaccharides in polyacrylamide gels. Electrophoresis 20:462-465.
19. Jiao, X., T. Hirano, Y. Hou, and X. X. Gu. 2002. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine. Infect. Immun. 70:5982-5989.
20. Li, J., P. Thibault, A. Martin, J. C. Richards, W. W. Wakarchuk, and W. van der Wilp. 1998. Development of an on-line preconcentration method for the analysis of pathogenic lipopolysaccharides using capillary electrophoresis- electrospray mass spectrometry. Application to small colony isolates. J. Chromatogr. A 817:325-336.
21. Ling, M. M., and B. H. Robinson. 1997. Approaches to DNA mutagenesis: an overview. Anal. Biochem. 254:157-178.
22. Luke, N. R., S. Allen, B. W. Gibson, and A. A. Campagnari. 2003. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infect. Immun. 71:6426-6434.
23. Masoud, H., M. B. Perry, J.-R. Brisson, D. Uhrin, and J. C. Richards. 1994. Structural elucidation of the backbone oligosaccharide for the lipopolysaccharide of Moraxella catarrhalis serotype A. Can. J. Chem. 72:1466-1477.
24. McMahon, M., T. F. Murphy, J. Kyd, and Y. Thanavala. 2005. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 23:3590-3596.
25. Meier, P. S., N. Heiniger, R. Troller, and C. Aebi. 2003. Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect. Immun. 71:6793-6798.
26. Menard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
27. Murphy, T. F. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279.
28. Murphy, T. F., A. L. Brauer, C. Aebi, and S. Sethi. 2005. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect. Immun. 73:8161-8166.
29. Murphy, T. F., A. L. Brauer, C. Aebi, and S. Sethi. 2005. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect. Immun. 73:3471-3478.
30. Murphy, T. F., A. L. Brauer, B. J. Grant, and S. Sethi. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am. J. Respir. Crit. Care Med. 172:195-199.
31. Murphy, T. F., S. Sethi, and M. S. Niederman. 2000. The role of bacteria in exacerbations of COPD. A constructive view. Chest 118:204-209.
32. Novotny, L. A., and L. O. Bakaletz. 2003. The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypable Haemophilus influenzae is an immunodominant but nonprotective decoying epitope. J. Immunol. 171:1978-1983.
33. Peak, I. R., I. D. Grice, I. Faglin, Z. Klipic, P. M. Collins, L. van Schendel, P. G. Hitchen, H. R. Morris, A. Dell, and J. C. Wilson. 2007. Towards understanding the functional role of the glycosyltransferases involved in the biosynthesis of Moraxella catarrhalis lipooligosaccharide. FEBS J. 274:2024-2037.
34. Plamondon, P., N. R. Luke, and A. A. Campagnari. 2007. Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infect. Immun. 75:2929-2936.
35. Plested, J. S., M. A. Gidney, P. A. Coull, H. G. Griffiths, M. A. Herbert, A. G. Bird, J. C. Richards, and E. R. Moxon. 2000. Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B. J. Immunol. Methods 237:73-84.
36. Rabe, K. F., S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, and J. Zielinski. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary. Am. J. Respir. Crit. Care Med. 176:532-555.
37. Rahman, M., and T. Holme. 1996. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J. Med. Microbiol. 44:348-354. (Pubitemid 26167179)
38. Rahman, M., T. Holme, I. Jonsson, and A. Krook. 1995. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection. Eur. J. Clin. Microbiol. Infect. Dis. 14:297-304.
39. Ruckdeschel, E. A., C. Kirkham, A. J. Lesse, Z. Hu, and T. F. Murphy. 2008. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect. Immun. 76:1599-1607.
40. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Schwingel, J. M., F. St. Michael, A. D. Cox, H. Masoud, J. C. Richards, and A. A. Campagnari. 2008. A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology 18:447-455.
42. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471.
43. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
44. Tobin, G. J., J. D. Trujillo, R. V. Bushnell, G. Lin, A. R. Chaudhuri, J. Long, J. Barrera, L. Pena, M. J. Grubman, and P. L. Nara. 2008. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199.
45. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
46. Vaneechoutte, M., G. Verschraegen, G. Claeys, and A. M. Van Den Abeele. 1990. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J. Clin. Microbiol. 28:182-187.
47. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144.
48. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of procedure, p. 83-91. In R. Whistler (ed.), Methods in carbohydrate chemistry, vol.5. Academic Press, New York, NY.
49. Wilson, J. C., P. M. Collins, Z. Klipic, I. D. Grice, and I. R. Peak. 2006. Identification of a novel glycosyltransferase involved in LOS biosynthesis of Moraxella catarrhalis. Carbohydr. Res. 341:2600-2606.
50. Yi, K., and T. F. Murphy. 1997. Importance of an immunodominant surface-exposed loop on outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect. Immun. 65:150-155. (Pubitemid 27008916)
51. Yi, K., S. Sethi, and T. F. Murphy. 1997. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J. Infect. Dis. 176:1247-1252.
52. Yu, S., and X. X. Gu. 2005. Synthesis and characterization of lipooligosaccharide- based conjugate vaccines for serotype B Moraxella catarrhalis. Infect. Immun. 73:2790-2796.
53. Yu, S., H. Xie, A. Datta, N. Naidu, and X.-X. Gu. 2008. Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination. Infect. Immun. 76:4251-4258.
54. k (Galα1-4Galβ1-4Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect. Immun. 68:5261-5268.